Evolving best practices: considerations for conventional and spectral flow
Thursday 6 June 2024
07:00 [PST] 10:00 [EST] 15:00 [BST]
Alternative time zones
Discover the power of flow cytometry best practices for standardization and reliable data in your drug development journey.
‘Evolving best practices: considerations for conventional and spectral flow’ explores the dynamic field of flow cytometry. As scientific advancements push the boundaries of cellular analysis, it is critical to understand best practices in optimizing protocols and instrumentation for conventional and spectral flow cytometry to support non-clinical and clinical drug development. Whether you are a seasoned researcher or new to the field, this webinar provides practical advice on adopting the latest innovations in flow cytometry to ensure accurate and reproducible results.
What will you learn?
• Primer on the basics of conventional and spectral flow cytometry
• Understand best practices for instrument maintenance and standardization
• Understand advancements and advantages of spectral flow
• Understand how investing time in robust panel development can have broad applications to your research
Who may this interest?
Researchers and procurement professionals looking to:
- Learn more about conventional versus spectral flow
- Understand practical tips to trouble shoot their assays
- Stay current with the evolving best practices in this rapidly advancing field
Speaker
Christy Bucks
Scientific Advisor
KCAS Bio (KS, USA)
Christy is currently a Scientific Advisor at KCAS Bio (KS, USA), supporting flow cytometry services. She has 15 years of experience utilizing flow cytometry techniques, inclusive of nearly 8 years in the CRO space. She has previously worked at FlowMetric Life Sciences (PA, USA) and prior to that at Centocor (PA, USA), a part of the Johnson & Johnson family of companies. She received her PhD in Immunology at Drexel University College of Medicine (PA, USA) and works out of the Central Pennsylvania area.
In association with
